Kathleen Giacomini

Last updated
Kathleen M. Giacomini
Education University at Buffalo
Honors Scheele Award (2011)

Kathleen M. Giacomini is a professor of bioengineering and therapeutic sciences at the University of California, San Francisco. Her work focuses on how genetics affects the efficacy of drugs. [1] She is also the co-director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation for the department of Bioengineering at the University of California, San Francisco.

Contents

Giacomini has organized Health Care conferences in the San Francisco Bay Area [2]

Education

Giacomini earned her doctorate in pharmaceutics from the University at Buffalo. From 1979 to 81, Giacomini was a post-doctoral fellow in clinical pharmacology at Stanford University. [3]

Career

In 1998, Giacomini was named chair of the department of biopharmaceutical sciences at the University of California San Francisco. [4] In 1999, Giacomini became the first woman honored as Pharmaceutical Scientist of the Year by the International Pharmaceutical Federation. [5] In 2000, Giacomini organized the Pharmacogenomics of Membrane Transporters (PMT) Project at the University of California, San Francisco. [6] In 2005, while serving as vice chair of the Pharmacogenetics Research Network, Giacomini was awarded the Paul Dawson Biotechnology Award by the American Association of Colleges of Pharmacy. [4]

In 2010, Giacomini received the Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy. [7] The following year she was awarded the Scheele Award for her work on the pharmacogenetics of drug transporters. [8] In 2014, Giacomini became the co-director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation for the department of Bioengineering. [9] [10]

In 2018, Giacomini was awarded the Bill Heller Mentor of the Year Award by the American Foundation for Pharmaceutical Education [11] and the Volwiler Research Award. [12]

Related Research Articles

<span class="mw-page-title-main">University of California, San Francisco</span> Public university in San Francisco, California

The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.

<span class="mw-page-title-main">Pharmacogenomics</span> Study of the role of the genome in drug response

Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of a patient affects their response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response, by correlating DNA mutations with pharmacokinetic, pharmacodynamic, and/or immunogenic endpoints.

<span class="mw-page-title-main">Russ Altman</span>

Russ Biagio Altman is an American professor of bioengineering, genetics, medicine, and biomedical data science and past chairman of the bioengineering department at Stanford University.

<span class="mw-page-title-main">California Institute for Quantitative Biosciences</span>

The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three University of California campuses in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.

Joseph T. DiPiro is professor and Associate Vice President of Health Sciences for Faculty Affairs at Virginia Commonwealth University From 2014 to 2022 he was Dean and Archie O. McCalley Chair, School of Pharmacy.

<span class="mw-page-title-main">UCSF School of Dentistry</span> Graduate school in San Francisco

The UCSF School of Dentistry is the dental school of the University of California, San Francisco, in San Francisco, California, in the United States. It was founded in 1881 and is the oldest dental school in California and the western United States. It is accredited by the American Dental Association. In 2016, it had received the highest NIH funding of any US dental school for 25 consecutive years. It is one of the top dental schools in the world, being ranked #5 by QS World University Rankings and 7 by Academic Ranking of World Universities.

<span class="mw-page-title-main">William E. Evans (pharmacist)</span>

Dr. William E. Evans, Pharm.D. served as St. Jude Children’s Research Hospital’s fifth director and CEO from 2004 to 2014. From 1986 to 2002, he chaired the St. Jude Department of Pharmaceutical Sciences, and from 2002 to 2004 served as the hospital’s scientific director and executive vice president. He also currently holds the St. Jude Professorship and Endowed chair at the University of Tennessee College of Medicine and Pharmacy.

Steven Shafer is a professor of anesthesiology at Stanford University. In 2011, the International Society of Anaesthetic Pharmacology gave him their lifetime achievement award.

<span class="mw-page-title-main">Lisa Bero</span> American scientist

Lisa Anne Bero, born 1958, is an academic who originally trained in pharmacology and went on to a career studying research integrity and how clinical and basic sciences are translated into clinical practice and health policy. Bero is a Professor of Medicine and Public Health and the Chief Scientist of the Center for Bioethics and Humanities at the University of Colorado. Previously, she had been Chair of Medicines Use and Health Outcomes at the University of Sydney. From 1991 until 2014, she was Professor in the Department of Clinical Pharmacy and in the Institute of Health Policy Studies at the University of California, San Francisco (UCSF), and is currently an adjunct professor there. She is also Chair of the World Health Organization (WHO) Essential Medicines Committee, Director of the WHO Collaborating Centre for Pharmaceutical Research and Science Policy, and was Co-Chair of the Cochrane Collaboration from 2013 to 2017. Bero has received multiple awards for her extensive mentoring of high school students to junior faculty.

Leor S. Weinberger is an American virologist and quantitative biologist. He is credited with discovering the HIV virus latency circuit, which provided the first experimental evidence that stochastic fluctuations ('noise') in gene expression are used for cell fate decisions. He has also pioneered the concept of therapeutic interfering particles, or “TIPs”, which are resistance-proof antivirals. His TED talk on this novel antiviral approach 20 years in the making has been called a "highlight" of TED and received a standing ovation from the live audience.

<span class="mw-page-title-main">Leslie Z. Benet</span>

Leslie 'Les' Zachary Benet is an influential pharmaceutical scientist heading the UCSF's Benet Lab at the Department of Bioengineering and Therapeutic Sciences and recipient of the Remington Medal for distinguished service to American pharmacy.

<span class="mw-page-title-main">UCSF School of Pharmacy</span> School of the U of California, San Francisco

UCSF School of Pharmacy, is the pharmacy school of the University of California, San Francisco, and is located in San Francisco. Founded in 1872, it is the oldest pharmacy school in California and the western United States. For 41 consecutive years it has been the top recipient of NIH funding among all US pharmacy programs, with a total of $40.9 million in awards in 2020. In 2020, it was ranked second nationwide by U.S. News & World Report.

Hartmut Derendorf was a German-American pharmacist and clinical pharmacologist, a distinguished emeritus professor of pharmaceutics at University of Florida. A significant figure in his field, Derendorf published over 20 papers each with over 100 citations.

Catherine Sohn is an American businesswoman, pharmacist, and consultant specializing in therapeutic commercialization and licensing.

Tanja Kortemme is a bioengineering professor at University of California, San Francisco. She has been recognized for outstanding contributions in computational protein design, including energy functions, sampling algorithms, and molecules to rewire cellular control circuits. She was an inaugural Chan Zuckerberg Biohub investigator and was inducted into American Institute for Medical and Biological Engineering College of Fellows.

Esteban González Burchard is an American physician-scientist, a distinguished professor in the School of Pharmacy at University of California at San Francisco,a specialist in gene-environment interactions in asthma and health disparities.

<span class="mw-page-title-main">Julie A. Johnson</span> American clinical pharmacist

Julie Ann Johnson is an American clinical pharmacist and translational scientist. She is the past dean (2013-2022) and a distinguished professor in the University of Florida College of Pharmacy and a Member of the National Academy of Medicine. For four consecutive years, she was a Clarivate Analytics Highly Cited Researcher in Pharmacology and Toxicology, indicating she was one of the "world's leading scholars in the sciences and social sciences in the preceding decade."

Malcolm Rowland FBPhS is Emeritus Professor of Pharmacy, University of Manchester, and Adjunct Professor, University of California San Francisco. His research in pharmacology, has been particularly in physiologically based pharmacokinetics. He has written several textbooks on the subject.

The Quantitative Biosciences Institute (QBI) was established in 2016 as an organized research unit (ORU) within the School of Pharmacy at the University of California-San Francisco. The current director of QBI is Nevan Krogan.

Danica Galonić Fujimori is a Serbian-American chemical biologist who is a professor at the University of California, San Francisco. Her research considers nucleic acid synthesis and tissue engineering. In the search for new therapeutics and vaccines, she has studied the interactions between ribosomes and SARS-CoV-2.

References

  1. ↑ "2016 NIH Funding: A Look at Top Recipients and Their Research". University of California San Francisco. Retrieved 4 April 2019.
  2. ↑ "Federal shutdown cancels conference aimed at health care cooperation". Biz Journals. Retrieved 4 April 2019.
  3. ↑ Suzanne Chamberlain (March 29, 2002). "Noted Researcher to Speak on Drugs and Genes in the First Gerhard Levy Distinguished Lecture". buffalo.edu. Retrieved April 5, 2019.
  4. 1 2 "Giacomini Receives Dawson Award". pharmacy.ucsf.edu. July 19, 2005. Retrieved April 5, 2019.
  5. ↑ "UCSF professor receives Pharmaceutical Scientist of the Year Award". eurekalert.org. September 6, 1999. Retrieved April 5, 2019.
  6. ↑ "Giacomini, Haines, Johnson, and Kane to Receive ACCP Honors". accp.com. Retrieved April 5, 2019.
  7. ↑ "Giacomini to receive Therapeutic Frontiers Lecture Award". pharmacy.ucsf.edu. October 14, 2010. Retrieved April 5, 2019.
  8. ↑ "The Scheele Award 2011 to Professor Kathleen M. Giacomini for her pioneering work on the pharmacogenetics of drug transporters". mynewsdesk.com. January 11, 2011. Retrieved April 5, 2019.
  9. ↑ Barry, Fiona (May 21, 2014). "US FDA founds regulatory science centre with UCSF and Stanford". .in-pharmatechnologist.com. Retrieved April 5, 2019.
  10. ↑ Ron Leuty (May 5, 2014). "Stanford, UCSF target better drug development in new FDA partnership". bizjournals.com. Retrieved April 5, 2019.
  11. ↑ Burningham, Grant (September 17, 2018). "Giacomini receives Bill Heller Mentor of the Year Award". pharmacy.ucsf.edu. Retrieved April 5, 2019.
  12. ↑ Burningham, Grant (April 16, 2018). "Giacomini named 2018 Volwiler Research Award recipient". pharmacy.ucsf.edu. Retrieved April 5, 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.